The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Australian natural skincare company Skin Elements (SKN) has secured a $20 million funding facility with LDA Capital
  • Under the agreement, Skin Elements will issue shares to LDA Capital over the next three years at a floor price determined by Skin Elements
  • Funds from the agreement will give the company ready access to additional equity to support both its growth into new markets and existing channels
  • On the market, Skin Elements last traded at 10 cents per share

Skin Elements (SKN) has secured a $20 million funding facility with LDA Capital.

The parties have signed a put option agreement, which will see LDA provide Skin Elements up to $20 million in committed equity capital over the next 36 months.

Under the agreement, Skin Elements will issue shares to LDA Capital over the next three years at a floor price determined by Skin Elements and will receive funds for the issue of those shares.

Funds from the agreement will give the company ready access to additional equity to support both its growth into new markets and existing channels.

Last year, the natural skincare company applied for a Therapeutic Goods Administration (TGA) registration for its sanitising disinfectant, Invisi Shield — a hospital-grade disinfectant.

“Successful registration with the TGA will allow the company to make more
detailed and specific product and label claims in respect to Invisi Shield which has the potential to open up significant new commercial-scale sales and distribution opportunities,” the company explained to the market.

“We are excited to have secured this $20 million equity funding facility from LDA Capital,” Chairman Peter Malone said.

“LDA Capital has a track record of providing funding to help emerging growth
companies achieve their business goals, and we are delighted to see that LDA Capital shares the same positive view on the global growth potential of our Invisi Shield sanitising disinfectant and our range of natural skincare products as we do,” he added.

On the market, Skin Elements is suspended and last traded at 10 cents per share.

SKN by the numbers
More From The Market Online
Image of a woman holding a bottle of hemp oil

Little Green Pharma jumps into distribution with acquisition

Little Green Pharma is aiming to make the strategic acquisition of HH (Australia) Pty Ltd to…
Image of cancer cells

Radiopharm approved to start Lu-RAD202 safety trials, door open for in-human studies

Radiopharm Theranostics has received ethics approval for its trial into Lu-RAD202, a novel treatment for these…
Close up of a nasal spray

LTR Pharma pairs with Men’s Health Downunder for supply of erectile dysfunction spray

LTR Pharma Ltd has signed an agreement with Men's Health Downunder to facilitate supply of its…
Immune system concept ai gen

Immutep dips as safety test for flagship drug IMP761 shows no adverse effects

Immutep has reported a small-scale conceptual safety test among 5 patients using flagship drug IMP761 has…